X-Linked Lymphoproliferative

Download PDF

Recent Publications on X-Linked Lymphoproliferative:
Physical and functional characterization of the genetic locus of IBtk, an inhibitor of Bruton's tyrosine kinase: evidence for three protein isoforms of IBtk. Bruton's tyrosine kinase (Btk) is required for B-cell development. Btk...	4th July, 2008	Department of Experimental and Clinical Medicine, University of Catanzaro	Nucleic Acids Res. 2008 Jul 2;. DOI Direct Link
[The possible curative therapy for rheumatoid arthritis--EBV infection control gene SAP and its application] Epstein-Barr virus (EBV) belong to herpes virus group. This virus is...	1st July, 2008	Division of Hematology and Rheumatology, Department of Medicine, Nihon	Nihon Rinsho Meneki Gakkai Kaishi. 2008 Jun;31(3):141-51.
Atypical lymphoproliferative disorder in a patient with X-linked thrombocytopenia. Epstein-Barr virus (EBV) belong to herpes virus group. This virus is...	5th June, 2008	Department of Pediatrics, Graduate School of Medicine, University of	Pediatr Blood Cancer. 2008 Jun 3;51(3):443-444. DOI Direct Link
Sequence Analysis of BIRC4/XIAP in Male Patients with Common Variable Immunodeficiency. Background: Common variable immunodeficiency (CVID) is the most common...	4th June, 2008	Division of Rheumatology and Clinical Immunology, Medical School,	Int Arch Allergy Immunol. 2008 Jun 3;147(2):147-151. DOI Direct Link
Epstein-Barr virus persistence in the absence of conventional memory B cells: IgM+IgD+ CD27+ B cells harbour the virus in X-linked lymphoproliferative disease patients. Epstein-Barr virus (EBV) persists in healthy virus carriers within the...	30th May, 2008	Institute for Cancer Studies, University of Birmingham, Birmingham, United	Blood. 2008 May 28;. DOI Direct Link
→View more research publications.

X-Linked Lymphoproliferative Clinical Trials:
Genetic Studies of X-Linked Lymphoproliferative Disease	X-Linked Lymphoproliferative Disease;   Lymphoproliferative Disease;   Genetic Diseases, X-Linked

X-Linked Lymphoproliferative Patents:
US Patent No.	Title
7041499	Immuno activation of CS1 receptor in natural killer cells to inhibit tumor cell growth
7138501	Antibodies that immunospecifically bind BLyS
7141547	Albumin fusion proteins comprising GLP-1 polypeptides
7141569	Antiviral pyrazolopyridine compounds
7153855	Pyrazolopyridinyl pyrimidine therapeutic compounds
→View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for X-Linked Lymphoproliferative scientists - we have details of around 41 individuals working on X-Linked Lymphoproliferative .

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.